Latest filing published 29 May 2009 for Lineage Cell Therapeutics, Inc., €48k.
Insider track record
No signal scores available.
Harold D. Waitz: trading record in brief
Harold D. Waitz discloses dealings in Lineage Cell Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 28 May 2009 to 29 May 2009, the count stands at 11 filings.
The open-market record consists of 9 sales worth €73k, with no purchase. The rest of the record consists of 2 option exercises.
The newest entry dates from 29 May 2009: an option exercise of €48k, in Lineage Cell Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Harold D. Waitz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 34,000 shares@ US$2.00Common Shares, no par valueSEC:0001209191-09-029696:0
- 17,300 shares@ US$2.95Common Shares, no par valueSEC:0001209191-09-029696:1
- 600 shares@ US$2.87Common Shares, no par valueSEC:0001209191-09-029696:2
- 4,100 shares@ US$2.85Common Shares, no par valueSEC:0001209191-09-029696:3
- 5,500 shares@ US$2.84Common Shares, no par valueSEC:0001209191-09-029696:4
- 2,928 shares@ US$2.80Common Shares, no par valueSEC:0001209191-09-029696:5
- 3,572 shares@ US$2.77Common Shares, no par valueSEC:0001209191-09-029696:6
- 16,000 shares@ US$2.00Common Shares, no par valueSEC:0001209191-09-029696:7
- 500 shares@ US$2.70Common Shares, no par valueSEC:0001209191-09-029696:8
- 1,000 shares@ US$2.72Common Shares, no par valueSEC:0001209191-09-029696:9
- 500 shares@ US$2.73Common Shares, no par valueSEC:0001209191-09-029696:10
11 of 11 declarations